Join to View Full Profile
1331 N 7th St Ste 250Phoenix, AZ 85006
Phone+1 602-354-5770
Fax+1 602-354-5607
Dr. Ackerman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tulane UniversityResidency, Dermatology, 2004 - 2007
University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 2003 - 2004
University of Arizona College of MedicineClass of 2003
Certifications & Licensure
AZ State Medical License 2007 - 2027
LA State Medical License 2004 - 2009
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Aprima PRM 2015, Aprima Medical Software, Inc., 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification Aprima, Aprima Medical Software, Inc., 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification PRM 2014, Aprima Medical Software, Inc., 2011, 2013-2017
Clinical Trials
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- Disseminated coccidioidomycosis masquerading as bacterial cellulitis.Santana Maria Bachaalany, Nelson Nicolasora, Lindsay Ackerman, Ghassan Ibrahim, Trent Smith
Cleveland Clinic Journal of Medicine. 2026-06-01 - Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.Alexa B Kimball, Konrad T Sawicki, Lindsay Ackerman, Hermenio Lima, Evangelos J Giamarellos-Bourboulis
JAMA Dermatology. 2026-05-01 - 1 citationsLebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: R...Jonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, Linda Stein Gold, Andrew Blauvelt
Dermatology and Therapy. 2026-02-01
Press Mentions
🌟 Member Spotlight: Lindsay Ackerman, MDDecember 8th, 2025- 2025 ArMA Health Care Awards Presented to Local Champions, Leaders During Arizona Physicians MonthApril 10th, 2025
- Interview: Lindsay AckermanApril 8th, 2025
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
